{"id":"W4396869098","doi":"10.1080/09546634.2024.2324833","title":"Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Placebo; Dermatology; Clinical trial; Clinical efficacy; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008037639,0.00123373,0.003637772,0.0003883154,0.0004812307,0.001274298,0.0008504834,0.001459245,0.002354231],"category_scores_gemma":[0.004862433,0.0005479899,0.004801771,0.0005634067,0.0008790963,0.0008753113,0.0005688472,0.00203749,0.0003436078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006956072,"about_ca_system_score_gemma":0.00138506,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006119722,"about_ca_topic_score_gemma":0.002340088,"domain_scores_codex":[0.9974069,0.001567149,0.0002745403,0.0002719931,0.0002774672,0.0002019426],"domain_scores_gemma":[0.9963025,0.001316105,0.001190475,0.0003262039,0.0003387361,0.0005260045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.901926,0.009622615,0.01220769,0.003349577,0.01175758,0.0001098724,0.0002218345,0.0008287064,0.006161784,0.0001068741,0.001348091,0.05235928],"study_design_scores_gemma":[0.8189424,0.1472954,0.02356449,0.0002837579,0.006232332,0.000178869,0.00008662417,0.0004167726,0.001095132,0.0001944139,0.001675269,0.00003449117],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9677129,0.02285301,0.001139938,0.0005106834,0.0001790547,0.004821811,0.001391487,0.0001034853,0.001287492],"genre_scores_gemma":[0.9789686,0.009576787,0.002354657,0.001081298,0.0002826357,0.005382612,0.001459025,0.00002729028,0.0008669694],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008037639,"threshold_uncertainty_score":0.04250765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1029242243129192,"score_gpt":0.3948028931438463,"score_spread":0.291878668830927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}